Startseite/Aktien/CRON

CRON

USD

Cronos Group Inc. Common Share

$2.480+0.030 (1.224%)

Echtzeitkurs

Healthcare

Drug Manufacturers - Specialty & Generic

Kanada

Kursdiagramm

Loading Chart...

Schlüsselkennzahlen

Marktkennzahlen

Unternehmensfundamentaldaten

Handelsstatistiken

Marktkennzahlen

Eröffnung

$2.450

Hoch

$2.500

Tief

$2.425

Volumen

1.24M

Unternehmensfundamentaldaten

Marktkapitalisierung

949.6M

Branche

Drug Manufacturers - Specialty & Generic

Land

Canada

Handelsstatistiken

Durchschnittliches Volumen

2.79M

Börse

NGM

Währung

USD

52-Wochen-Spanne

Tief $1.6Aktuell $2.480Hoch $3.16

Ähnliche Nachrichten

1. Nov. 2025 · 12:00

CNBC

'Trump effect' raises hopes for cannabis rally as investors bet on federal reforms, softer marijuana stance

Cannabis stocks could rally on hopes for new hemp regulations and Trump's possible softer stance on marijuana, fueling investor optimism across the industry.

'Trump effect' raises hopes for cannabis rally as investors bet on federal reforms, softer marijuana stance

28. Okt. 2025 · 11:30

GlobeNewswire

Cronos Brings Back Popular, Limited-Edition Spinach® Green Apple-Flavored Products for the Fall Season

TORONTO, Oct. 28, 2025 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ:CRON) (TSX:CRON) ("Cronos"), an innovative global cannabinoid company, announced today that it is welcoming back its limited-edition Caramel Green

Cronos Brings Back Popular, Limited-Edition Spinach® Green Apple-Flavored Products for the Fall Season

23. Okt. 2025 · 11:30

GlobeNewswire

Cronos Group Inc. to Hold 2025 Third Quarter Earnings Conference Call on November 6, 2025

TORONTO, Oct. 23, 2025 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ:CRON) (TSX:CRON) ("Cronos" or the "Company") will hold its 2025 third quarter earnings conference call on Thursday, November 6, 2025 at 8:30 a.m. ET.